LABOMAR CANADA
Adrian Barbant is an experienced procurement professional with a strong background in the pharmaceutical, nutraceutical, and cosmetics sectors. Currently serving as Purchasing Manager at LABOMAR CANADA since May 2025, Adrian oversees full-cycle procurement, achieving significant cost reductions through strategic supplier consolidation and negotiations. Previous roles include Procurement Manager at Starpax Biopharma and Capcium Inc., where Adrian successfully managed procurement processes, securing favorable terms with suppliers. A history of roles at Neptune Wellness Solutions, DiversiTech, Karlo Corporation, Casco Petroleum Overseas, and Dita Est Pharm showcases extensive expertise in sourcing, logistics management, and contract negotiation. Adrian holds a Bachelor’s Degree in Business Administration and Management from the Economic Academy and a High School diploma in Accounting and Finance from Financial and Bank College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
LABOMAR CANADA
We are committed to contributing to society’s better health. Established in 1990 in Montreal, Canada, we are a pharmaceutical company with more than 30 years’ experience in the manufacturing of semi-solid (creams, ointments, gels, lotions) and liquid products. Our core business area is the development, production and packaging of top-quality products for the pharmaceutical, cosmetic and nutraceutical industry. The Company became part of the Labomar Group in 2019 and in 2023 changes its business name to Labomar Canada. Our mission is to provide customer-driven manufacturing services of the highest quality with products that will meet and exceed current and evolving client’s expectations. Our objective is to maintain our position as a reliable reference point in the manufacturing of quality pharmaceutical products: essentially, a benchmark for modern, efficient production, assured through the use of highly performing equipment. Labomar Canada offers manufacturing capabilities ranging from laboratory to pilot batches to scale-ups. The facilities are approved and inspected by Health Canada and FDA and registered under accredited GMP pharmaceutical standards.